04/24/2024
6:05 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024
11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
04/18/2024
6:00 AM | RedHill Biopharma (Filer)
| Form POS AM | |
04/08/2024
8:25 AM | RedHill Biopharma (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/08/2024
8:28 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024
3:05 PM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/03/2024
6:00 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
04/02/2024
6:02 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2024
3:38 PM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024
6:01 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2024
6:01 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/20/2024
6:01 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/16/2024
7:54 AM | RedHill Biopharma (Filer)
| Form 424B3 | |
02/15/2024
11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
02/09/2024
3:20 PM | RedHill Biopharma (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
02/05/2024
7:00 AM | RedHill Biopharma (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/01/2024
9:22 AM | CVI Investments, Inc. (Filed by)
RedHill Biopharma (Subject)
| Form SC 13G | |
01/26/2024
11:50 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/26/2024
8:29 AM | RedHill Biopharma (Filer)
| Form 424B5 | |
01/26/2024
8:31 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024
8:09 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/25/2024
5:02 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
9:23 AM | Empery Asset Management, LP (Filed by)
RedHill Biopharma (Subject)
| Form SC 13G/A | |
01/02/2024
3:26 PM | RedHill Biopharma (Subject)
SABBY MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
12/20/2023
7:45 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023
6:03 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/06/2023
6:01 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023
6:03 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/01/2023
3:10 PM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/27/2023
6:01 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/16/2023
11:00 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/26/2023
11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
10/26/2023
3:52 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
10/23/2023
3:06 PM | RedHill Biopharma (Filer)
| Form F-3/A | |
10/16/2023
3:05 PM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/13/2023
7:13 AM | RedHill Biopharma (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
10/12/2023
3:05 PM | RedHill Biopharma (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/10/2023
8:08 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023
6:03 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023
7:02 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/22/2023
3:17 PM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Could Your Accounts Be Frozen? (Ad) The US Dollar Is "Finished"
A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit |
09/18/2023
6:03 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2023
6:03 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/17/2023
6:07 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/13/2023
11:15 PM | RedHill Biopharma (Filer)
| Form EFFECT | |
08/11/2023
3:52 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
08/09/2023
8:00 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2023
8:00 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023
6:04 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/31/2023
6:03 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2023
12:31 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
07/25/2023
12:33 PM | RedHill Biopharma (Filer)
| Form 424B3 | |
07/25/2023
11:09 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2023
7:00 AM | RedHill Biopharma (Filer)
| Form 424B5 | |
07/21/2023
8:37 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/21/2023
6:02 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/06/2023
6:00 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023
6:00 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/29/2023
6:10 AM | RedHill Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/12/2023
7:01 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2023
6:02 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/09/2023
6:02 AM | RedHill Biopharma (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
